Exploring how the microbiome affects autoimmune diseases
Micro-TeACH (Microbiome Technology and Analytic Center Hub)
['FUNDING_OTHER'] · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · NIH-11034105
This study is exploring how the tiny organisms in our gut might affect autoimmune diseases like rheumatoid arthritis and lupus, with the goal of finding better ways to personalize treatments and improve care for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY SCHOOL OF MEDICINE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11034105 on ClinicalTrials.gov |
What this research studies
This research investigates the role of the human microbiome in autoimmune and immune-mediated diseases, such as rheumatoid arthritis and lupus. By analyzing the microbiome and gene expression, the study aims to understand how these microorganisms influence inflammatory responses and treatment outcomes. The approach includes pharmacomicrobiomics, which looks at how variations in the gut microbiome affect drug responses, potentially leading to more personalized treatment strategies for patients. The research seeks to identify biomarkers that could predict treatment efficacy and improve patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with autoimmune diseases like rheumatoid arthritis, lupus, or psoriatic arthritis.
Not a fit: Patients with non-autoimmune conditions or those who do not have a significant microbiome component to their disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective, personalized treatments for patients with autoimmune diseases.
How similar studies have performed: Other research has shown promising results in understanding the microbiome's role in autoimmune diseases, indicating that this approach could lead to significant advancements.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SCHER, JOSE U. — NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- Study coordinator: SCHER, JOSE U.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.